MJ BIOTECH, INC.: 10-Q filed 2017-12-29

Name: MJ BIOTECH, INC.: 10-Q filed 2017-12-29
Creator: MJ BIOTECH, INC.

What MJ BIOTECH, INC. reported in its quarterly report filed 2017-12-29 (fiscal Q3 2017): 23 published measures, 61 facts as tagged in accession 0001543272-17-000057.

This filing

Form: 10-Q (quarterly report)
Filed: 2017-12-29
Fiscal period: fiscal Q3 2017
Accession: 0001543272-17-000057 on SEC EDGAR

Values are as tagged in this filing. A later filing can restate them; each measure links to its history page, which shows the latest-filed value per period. All MJ BIOTECH, INC. filings.

Reported measures

Total assets

Resources recognized on the balance sheet. Book assets are not the market value of the business.

Period	Value	Unit	Days
At 2016-12-31	27,767	USD

Total liabilities

Recognized obligations at the reporting date. The definition and scope differ from interest-bearing debt.

Period	Value	Unit	Days
At 2017-09-30	1,374,151	USD
At 2016-12-31	975,107	USD

Cash and cash equivalents

Cash and qualifying short-term liquid investments under the filer’s accounting policy. Restricted cash and longer-term investments may be reported separately.

Period	Value	Unit
At 2016-12-31	26,767	USD
At 2016-09-30	40	USD
At 2015-12-31	300	USD

Net income or loss

Reported profit or loss for the period. Check the filing for attribution, exceptional items and discontinued operations before comparing companies.

Period	Value	Unit	Days
2017-01-01 to 2017-09-30	-6,190,380	USD	273
2016-01-01 to 2016-09-30	-1,811,006	USD	274

Operating cash flow

Cash generated or used by operating activities. Working-capital timing can make this differ substantially from reported income.

Period	Value	Unit	Days
2017-01-01 to 2017-09-30	-157,317	USD	273
2016-01-01 to 2016-09-30	-44,469	USD	274

Financing cash flow

Net cash from financing activities, including borrowing, repayments and transactions with owners. A positive amount does not establish operating profitability.

Period	Value	Unit	Days
2017-01-01 to 2017-09-30	130,550	USD	273
2016-01-01 to 2016-09-30	44,209	USD	274

Basic weighted-average shares

Time-weighted shares used for basic earnings per share. This denominator differs from shares outstanding at a single reporting date.

Period	Value	Unit	Days
2017-07-01 to 2017-09-30	30,315,979	shares	92
2017-01-01 to 2017-09-30	24,761,082	shares	273
2016-07-01 to 2016-09-30	18,851,502	shares	92
2016-01-01 to 2016-09-30	15,027,530	shares	274

Diluted weighted-average shares

Weighted-average shares used for diluted earnings per share. Potential shares are included under the applicable dilution rules, not simply added to outstanding shares.

Period	Value	Unit	Days
2017-07-01 to 2017-09-30	30,315,979	shares	92
2017-01-01 to 2017-09-30	24,761,082	shares	273
2016-07-01 to 2016-09-30	18,851,502	shares	92
2016-01-01 to 2016-09-30	15,027,530	shares	274

Basic earnings per share

Reported earnings or loss per basic common share or unit. Inspect attribution, share classes and restatements before comparing periods. This is not a market return.

Period	Value	Unit	Days
2017-07-01 to 2017-09-30	-0.01	USD/shares	92
2017-01-01 to 2017-09-30	-0.25	USD/shares	273
2016-07-01 to 2016-09-30	-0.04	USD/shares	92
2016-01-01 to 2016-09-30	-0.12	USD/shares	274

Diluted earnings per share

Reported earnings or loss per share under dilution rules. Antidilutive instruments may be excluded. A diluted value can equal the basic value without implying no potential dilution.

Period	Value	Unit	Days
2017-07-01 to 2017-09-30	-0.01	USD/shares	92
2017-01-01 to 2017-09-30	-0.25	USD/shares	273
2016-07-01 to 2016-09-30	-0.04	USD/shares	92
2016-01-01 to 2016-09-30	-0.12	USD/shares	274

Operating income or loss

Operating revenue less operating expenses for the reporting period. It excludes items outside the reported operating result and is not free cash flow.

Period	Value	Unit	Days
2017-07-01 to 2017-09-30	-11,369	USD	92
2017-01-01 to 2017-09-30	-5,761,972	USD	273
2016-07-01 to 2016-09-30	-900,908	USD	92
2016-01-01 to 2016-09-30	-1,349,623	USD	274

Current assets

Assets classified as current under the normal operating cycle or one-year boundary. Not all current assets can be converted immediately into cash.

Period	Value	Unit	Days
At 2016-12-31	27,767	USD

Interest expense

Borrowing costs recognized as interest expense. This is distinct from cash interest paid and may not include every capitalized borrowing cost.

Period	Value	Unit	Days
2017-07-01 to 2017-09-30	8,454	USD	92
2017-01-01 to 2017-09-30	142,304	USD	273
2016-07-01 to 2016-09-30	80,136	USD	92
2016-01-01 to 2016-09-30	283,809	USD	274

Current liabilities

Obligations classified as current under the operating-cycle or one-year boundary. The balance includes more than short-term borrowing.

Period	Value	Unit	Days
At 2017-09-30	1,374,151	USD
At 2016-12-31	975,107	USD

Net current accounts receivable

Current customer receivables after the allowance for credit loss. The balance is not cash collected or a guarantee of collection.

Period	Value	Unit	Days
At 2016-12-31	1,000	USD

Operating expenses

Recurring operating costs under this accounting concept, generally excluding production costs included in cost of sales. Check filing presentation before combining expense subtotals.

Period	Value	Unit	Days
2017-07-01 to 2017-09-30	11,369	USD	92
2017-01-01 to 2017-09-30	5,761,972	USD	273
2016-07-01 to 2016-09-30	900,908	USD	92
2016-01-01 to 2016-09-30	1,349,623	USD	274

Common shares outstanding

Common shares outstanding at the reporting date. This point-in-time count differs from the weighted-average shares used for earnings per share and can exclude other share classes.

Period	Value	Unit	Days
At 2017-09-30	32,303,283	shares
At 2016-12-31	22,315,946	shares

Additional paid-in capital

Capital contributed above par value under this concept. It records historical contributions, not the current value of the equity or cash on hand.

Period	Value	Unit	Days
At 2017-09-30	18,198,717	USD
At 2016-12-31	12,439,406	USD

Accumulated other comprehensive income or loss

Cumulative other comprehensive items after tax, such as translation and unrealized hedging or securities effects. These amounts have not passed through net income.

Period	Value	Unit	Days
At 2017-09-30	-19,579,425	USD
At 2016-12-31	-13,389,043	USD

Total equity including noncontrolling interests

Equity including the portion attributable to noncontrolling interests. It is larger than or equal to parent stockholders equity and is not market capitalization.

Period	Value	Unit	Days
At 2017-09-30	-1,374,151	USD
At 2016-12-31	-947,340	USD

Pre-tax income or loss from continuing operations

Income or loss from continuing operations before income taxes and noncontrolling interests. It excludes discontinued operations and is not net income.

Period	Value	Unit	Days
2017-07-01 to 2017-09-30	-230,368	USD	92
2017-01-01 to 2017-09-30	-6,190,380	USD	273
2016-07-01 to 2016-09-30	-832,282	USD	92
2016-01-01 to 2016-09-30	-1,811,006	USD	274

General and administrative expense

General and administrative costs reported under this concept, separate from selling expense. Filers group overhead differently, so compare presentation before comparing companies.

Period	Value	Unit	Days
2017-07-01 to 2017-09-30	11,369	USD	92
2017-01-01 to 2017-09-30	5,761,972	USD	273
2016-07-01 to 2016-09-30	900,908	USD	92
2016-01-01 to 2016-09-30	1,349,623	USD	274

Depreciation expense

Depreciation recognized for the period under this concept. It is a noncash allocation of asset cost and may exclude amortization and depletion reported elsewhere.

Period	Value	Unit	Days
2016-01-01 to 2016-09-30	1,953	USD	274

Inspect the source

Entity: MJ BIOTECH, INC. / CIK 0001543272
Captured: 2026-09-22 19:51 UTC
SEC response SHA-256: b61db2c53d74121c10e90bbc0851e213984888202b0ea0e1ce29c973caeef086

Current SEC company facts · Download the original response snapshot (gzip) · Download the selected JSON

Every published concept a filing tagged, with the periods it covered, as reported in that filing at capture time. Forms 10-K, 10-K/A, 10-Q, 10-Q/A, 20-F, 20-F/A, 40-F, 40-F/A. A filing page needs at least 8 published concepts. Later filings can restate these values; the company history pages show the latest-filed value per period.

Public company accounting reference, not market prices, returns, an investment recommendation, or ALPHAC performance. Validate a separately constructed return series with the validation API; accounting values are not returns.

Use this in research

A financial period ends before its results become public. Use the filing date as a minimum availability boundary, inspect amendments, and retain the original filing vintage when testing historical signals. This latest-filed selection can contain information unavailable at the time.

These pages do not supply prices, total-return histories, corporate-action adjustments or a tradable universe. Build those inputs separately before evaluating a strategy. A profitable backtest can still reflect selection bias or costs that were left out.

Research methodology · Execution and cost assumptions · Check backtest overfitting

Build with the open-source tools

Use these accounting records as inspectable inputs. When you have constructed a return series, the validation tools can help test its statistical evidence and preserve the result with its limitations.

Read the published dataset with Python

import json
from urllib.request import urlopen

with urlopen("https://canlicapital.com/company-data/0001543272.json") as response:
    record = json.load(response)
print(record["fetched_at"])
print(record["policy"])
for concept in record["concepts"]:
    print(concept["tag"], next(iter(concept["observations"])))